glp 1 compound fda is moving to restrict mass-marketed compounded GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified Laboratory Chemical Electrolyte+ Flavour:Blackcurrant Burst Health insurers raise questions

glp 1 compound fda is moving to restrict mass-marketed compounded GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified Laboratory Chemical Electrolyte+ Flavour:Blackcurrant Burst Health insurers raise questions

Health insurers raise questions about Medicare program that will offer GLP-1s to seniors for $50 - MarketWatch

“We want to get to 100% slowing and even prevention,” he said

Laboratory Chemical

Electrolyte+ Flavour:Blackcurrant Burst

Whether retatrutide is ultimately studied directly against tirzepatide will depend on regulatory and commercial priorities, but the scientific value of such a trial is obvious, because only a controlled comparison in a single population under a single protocol can convert the current cross-trial impression into an actual finding